作为冠状病毒抑制剂的天然产品:最新进展

Ritu Kalia, Sanjay Jachak, Akash Dey
{"title":"作为冠状病毒抑制剂的天然产品:最新进展","authors":"Ritu Kalia, Sanjay Jachak, Akash Dey","doi":"10.2174/0126667975269930231112093216","DOIUrl":null,"url":null,"abstract":"\n\nIn the past couple of decades, several corona virus infections have alarmed the world\nclaiming deaths of huge population over the globe. Effective anti-viral agents have been researched\nfor treatment of COVID-19 infection. Vaccination has come up as an ultimate prevention against\nSARS-CoV-2virus as many vaccines have been recommended by WHO to be used for prevention\nfrom COVID-19. Alternative treatment strategies to combat infection include drug repurposing as\nwell as supportive therapies. Traditional medicines being used from ancient times for different disease\nconditions provide a wealth of chemical diversity. Different classes of natural products are being\nutilized to study their antiviral properties and contributed in past for different viral diseases. The\naim of current review is to enumerate different secondary metabolites and their pharmacophoric features\nagainst corona viruses that can be further optimized to develop more potent inhibitors specific\nto SARS-CoV-2. This review systematically evaluates natural products and their synthetic/ semisynthetic\nanalogs belonging to terpenoids, polyphenols, saponins, and alkaloids having antiviral activity\nagainst coronaviruses. The information obtained from scope of Indian medicinal plants is also\ndiscussed which may be evaluated in future against SARS-CoV-2. Thus, it is proposed that the natural\nproducts may be used to develop potential inhibitors using the knowledge gained from similar\nstudies to prevent morbidity and mortalities due to SARS-CoV-2.\n","PeriodicalId":10815,"journal":{"name":"Coronaviruses","volume":" 860","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Natural Products as Inhibitors of Coronavirus: An Update\",\"authors\":\"Ritu Kalia, Sanjay Jachak, Akash Dey\",\"doi\":\"10.2174/0126667975269930231112093216\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n\\nIn the past couple of decades, several corona virus infections have alarmed the world\\nclaiming deaths of huge population over the globe. Effective anti-viral agents have been researched\\nfor treatment of COVID-19 infection. Vaccination has come up as an ultimate prevention against\\nSARS-CoV-2virus as many vaccines have been recommended by WHO to be used for prevention\\nfrom COVID-19. Alternative treatment strategies to combat infection include drug repurposing as\\nwell as supportive therapies. Traditional medicines being used from ancient times for different disease\\nconditions provide a wealth of chemical diversity. Different classes of natural products are being\\nutilized to study their antiviral properties and contributed in past for different viral diseases. The\\naim of current review is to enumerate different secondary metabolites and their pharmacophoric features\\nagainst corona viruses that can be further optimized to develop more potent inhibitors specific\\nto SARS-CoV-2. This review systematically evaluates natural products and their synthetic/ semisynthetic\\nanalogs belonging to terpenoids, polyphenols, saponins, and alkaloids having antiviral activity\\nagainst coronaviruses. The information obtained from scope of Indian medicinal plants is also\\ndiscussed which may be evaluated in future against SARS-CoV-2. Thus, it is proposed that the natural\\nproducts may be used to develop potential inhibitors using the knowledge gained from similar\\nstudies to prevent morbidity and mortalities due to SARS-CoV-2.\\n\",\"PeriodicalId\":10815,\"journal\":{\"name\":\"Coronaviruses\",\"volume\":\" 860\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Coronaviruses\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/0126667975269930231112093216\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Coronaviruses","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0126667975269930231112093216","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

在过去的几十年里,数次电晕病毒感染震惊了世界,导致全球大量人口死亡。为了治疗 COVID-19 感染,人们研究出了有效的抗病毒药物。疫苗接种已成为预防 SARS-CoV-2 病毒的最终方法,因为世界卫生组织已推荐使用多种疫苗来预防 COVID-19。抗感染的替代治疗策略包括药物再利用和支持疗法。自古以来用于治疗不同疾病的传统药物提供了丰富的化学多样性。人们正在利用不同类别的天然产物来研究它们的抗病毒特性,这些天然产物在过去治疗不同的病毒性疾病方面做出了贡献。本综述的目的是列举不同的次生代谢物及其针对冠状病毒的药效特征,以便进一步优化,开发出对 SARS-CoV-2 更有效的特异性抑制剂。本综述系统地评估了对冠状病毒具有抗病毒活性的天然产品及其合成/半合成类似物,包括萜类、多酚类、皂苷类和生物碱类。此外,还讨论了从印度药用植物范围中获得的信息,这些信息可能会在未来针对 SARS-CoV-2 进行评估。因此,建议利用从类似研究中获得的知识,将天然产品用于开发潜在的抑制剂,以防止 SARS-CoV-2 导致的发病率和死亡率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Natural Products as Inhibitors of Coronavirus: An Update
In the past couple of decades, several corona virus infections have alarmed the world claiming deaths of huge population over the globe. Effective anti-viral agents have been researched for treatment of COVID-19 infection. Vaccination has come up as an ultimate prevention against SARS-CoV-2virus as many vaccines have been recommended by WHO to be used for prevention from COVID-19. Alternative treatment strategies to combat infection include drug repurposing as well as supportive therapies. Traditional medicines being used from ancient times for different disease conditions provide a wealth of chemical diversity. Different classes of natural products are being utilized to study their antiviral properties and contributed in past for different viral diseases. The aim of current review is to enumerate different secondary metabolites and their pharmacophoric features against corona viruses that can be further optimized to develop more potent inhibitors specific to SARS-CoV-2. This review systematically evaluates natural products and their synthetic/ semisynthetic analogs belonging to terpenoids, polyphenols, saponins, and alkaloids having antiviral activity against coronaviruses. The information obtained from scope of Indian medicinal plants is also discussed which may be evaluated in future against SARS-CoV-2. Thus, it is proposed that the natural products may be used to develop potential inhibitors using the knowledge gained from similar studies to prevent morbidity and mortalities due to SARS-CoV-2.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
1.50
自引率
0.00%
发文量
0
期刊最新文献
COVID-19 Vaccine Effectiveness on the Severity of Disease: A Case-control Study in Southeastern Iran Evaluation of Influenza Vaccination Coverage Among Healthcare Workers During the COVID-19 Pandemic and Analysis of Motivating and Hindering Factors Novel Coronavirus: An Overview of the History, Pathophysiology, Diagnosis, and Management of the Pandemic COVID-19 Catastrophe, with Special Emphasis on Herbal Treatment Alternatives Spectrum of Long COVID Symptoms and Management Approaches in Europe and Latin America Identification of Epitope Against Omicron Variant of SARS-CoV-2: In Silico Vaccine Design Approach
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1